Issue 28, 2019

A thermoresponsive nanocarrier for mitochondria-targeted drug delivery

Abstract

Mitochondria emerge as an important target for cancer therapy. Herein, by taking advantage of the recently reported high temperature of mitochondria, a well-tuned thermoresponsive nanocarrier was developed for specifically delivering the anticancer drug, paclitaxel (PTX), to mitochondria in cancer cells. The temperature-dependent delivery of drugs to mitochondria represents a novel anticancer strategy.

Graphical abstract: A thermoresponsive nanocarrier for mitochondria-targeted drug delivery

Supplementary files

Article information

Article type
Communication
Submitted
23 Jan 2019
Accepted
06 Mar 2019
First published
06 Mar 2019

Chem. Commun., 2019,55, 4051-4054

A thermoresponsive nanocarrier for mitochondria-targeted drug delivery

D. Wang, H. Huang, M. Zhou, H. Lu, J. Chen, Y. Chang, J. Gao, Z. Chai and Y. Hu, Chem. Commun., 2019, 55, 4051 DOI: 10.1039/C9CC00603F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements